COMING SOON: @SKKN Resurfacing Pumpkin Enzyme Mask and Treatment Brush. Developed with cutting-edge biotechnology, our rinse-off exfoliating mask launches on October 4th alongside our application brush. Join the waitlist at the link in bio to shop first.

From the America Innovates stage, Timothy Springer, biotech founder, investor, and honoree on the Forbes 250 America’s Greatest Living Innovators list, on the medical advances helping keep cancer patients alive. ⠀ #Forbes250# #A250#

Suma Krishnan, Founder & President of Krystal Biotech, which is developing genetic medicines for rare diseases, on using AI to help automate business and manufacturing processes. ⁣ From the @america250 x Forbes America Innovates stage.⁣ ⁣ #Forbes250# #A250#

If Hantavirus mutated into a global threat, it would unleash AI + biotech unlike anything we've ever seen. > genome sequenced and public in 4 hours > AlphaFold maps every protein target > AI screens 10,000 drugs in 24 hrs > 50 vaccine candidates designed simultaneously > AI designed antibodies in days > risk of death computed instantly > decentralized trials launch globally > enroll from home > 20 countries manufacturing at once > first doses in three weeks > real-time dose characterization > your genome + biomarkers determine your protocol > variant map updates every hour No one would wait for governments.

The $SPX is near record highs, but Patrick Kennedy warns momentum is narrowing and a pullback may be needed before new entries. He favors cybersecurity names like $PANW and $CRWD, while also highlighting strength in biotech through the $XBI ETF. Gold and infrastructure assets remain key long-term diversifiers. For more market news, tune into:

Algorithms are part of nearly every aspect of life, from the physics of the natural world to planning shipping routes. Our Gemini-powered coding agent AlphaEvolve has been accelerating progress over the last year - from quantum and biotechnology to logistics and @Google’s AI infrastructure. ↓

🏁Pre-IPO New Listing: METIS TECHBIO-P is now open for subscription 🧬 Target: METIS TECHBIO-P 💰 Price: 1.35 USDT 📦 Minimum Subscription: 500 ⚡ Leverage Available: 5x ⏰ Subscription Period: May 5, 08:00 – May 7, 23:00 (UTC+8) A one-sentence introduction： A biotech company focused on AI-driven drug delivery and nano-formulations, using computation to enable precise drug targeting. 👉:

Vivek Ramaswamy, who ran for the 2024 GOP presidential nomination, will win the Republican primary for governor in Ohio, CNN projects. The biotech entrepreneur will face Democratic candidate Amy Acton, the former director of the Ohio Department of Health, who ran unopposed in the primary. Follow live updates: